Baldwin Investment Management, LLC Gilead Sciences, Inc. Transaction History

Baldwin Investment Management, LLC

$388 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $160,728 - $201,409	-2,775 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $236,811 - $268,786	-3,650 Reduced 56.81%	2,775 $201,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $10,153 - $10,954	-150 Reduced 2.28%	6,425 $449,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $17,962 - $19,626	-283 Reduced 4.13%	6,575 $453,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $69,000 - $78,729	-1,150 Reduced 14.36%	6,858 $443,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $63,278 - $72,102	-1,117 Reduced 12.24%	8,008 $467,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $110,227 - $138,592	1,775 Added 24.15%	9,125 $577,000
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $28,936 - $33,600	400 Added 5.76%	7,350 $566,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $3,131 - $4,011	-50 Reduced 0.71%	6,950 $520,000
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $6,162 - $6,778	-100 Reduced 1.41%	7,000 $455,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $31,255 - $34,500	500 Added 7.58%	7,100 $450,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $6,187 - $6,938	100 Added 1.54%	6,600 $446,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $56,277 - $63,045	-900 Reduced 12.16%	6,500 $423,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $36,324 - $47,400	-600 Reduced 7.5%	7,400 $463,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $10,692 - $11,838	-150 Reduced 1.84%	8,000 $618,000
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $32,439 - $37,840	-500 Reduced 5.78%	8,150 $577,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $19,666 - $23,976	-270 Reduced 3.03%	8,650 $652,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $102,456 - $120,268	-1,440 Reduced 13.9%	8,920 $639,000
Q2 2017 Aug 08, 2017	BUY	N/A	10,360	10,360 $733,000

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.

Account